Literature DB >> 12971430

Plasma and erythrocyte fatty acid concentrations in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.

A M Lund1, M A Dixon, P Vreken, J V Leonard, A A M Morris.   

Abstract

Plasma and erythrocyte fatty acids have been measured in 9 patients with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency being treated with a low-fat diet. No significant abnormality was detected and in particular docosahexaenoic acid was not deficient.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12971430     DOI： 10.1023/a:1025175606891

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN： 0141-8955            Impact factor:   4.982


  4 in total

1.  Docosahexaenoic acid and retinal function in children with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.

Authors:  C O Harding; M B Gillingham; S C van Calcar; J A Wolff; J N Verhoeve; M D Mills
Journal:  J Inherit Metab Dis       Date:  1999-05       Impact factor: 4.982

2.  Ophthalmologic findings in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency caused by the G1528C mutation: a new type of hereditary metabolic chorioretinopathy.

Authors:  T Tyni; T Kivelä; M Lappi; P Summanen; E Nikoskelainen; H Pihko
Journal:  Ophthalmology       Date:  1998-05       Impact factor: 12.079

3.  Assay of plasmalogens and polyunsaturated fatty acids (PUFA) in erythrocytes and fibroblasts.

Authors:  G Dacremont; G Vincent
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

4.  What is the role of medium-chain triglycerides in the management of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency?

Authors:  A M Lund; M A Dixon; P Vreken; J V Leonard; A A M Morris
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.750
  4 in total
  4 in total

1.  Effect of optimal dietary therapy upon visual function in children with long-chain 3-hydroxyacyl CoA dehydrogenase and trifunctional protein deficiency.

Authors:  Melanie B Gillingham; Richard G Weleber; Martha Neuringer; William E Connor; Monte Mills; Sandy van Calcar; James Ver Hoeve; Jon Wolff; Cary O Harding
Journal:  Mol Genet Metab       Date:  2005-07-22       Impact factor: 4.797

2.  Prolonged QT interval and lipid alterations beyond β-oxidation in very long-chain acyl-CoA dehydrogenase null mouse hearts.

Authors:  Roselle Gélinas; Julie Thompson-Legault; Bertrand Bouchard; Caroline Daneault; Asmaa Mansour; Marc-Antoine Gillis; Guy Charron; Victor Gavino; François Labarthe; Christine Des Rosiers
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-06-17       Impact factor: 4.733

Review 3.  Clinical and biochemical monitoring of patients with fatty acid oxidation disorders.

Authors:  Allan Meldgaard Lund; Flemming Skovby; Helle Vestergaard; Mette Christensen; Ernst Christensen
Journal:  J Inherit Metab Dis       Date:  2010-01-12       Impact factor: 4.982

4.  What is the role of medium-chain triglycerides in the management of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency?

Authors:  A M Lund; M A Dixon; P Vreken; J V Leonard; A A M Morris
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.750
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.